Milestone Pharmaceuticals Inc. - Common Shares (MIST)

Q3 2020 13F Holders as of 9/30/2020

Type / Class: Equity / Common Shares
Shares outstanding: 89.4M
Number of holders: 28
Total 13F shares, excl. options: 15.5M
Shares change: +5.72M
Total reported value, excl. options: $113M
Value change: +$42.8M
Number of buys: 17
Number of sells: -9
Price: $7.32

Significant Holders of Milestone Pharmaceuticals Inc. - Common Shares (MIST) as of Q3 2020

36 filings reported holding MIST - Milestone Pharmaceuticals Inc. - Common Shares as of Q3 2020.
Milestone Pharmaceuticals Inc. - Common Shares (MIST) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 15.5M shares of 89.4M outstanding shares and own 17.31% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (4.32M shares), RA CAPITAL MANAGEMENT, L.P. (2.42M shares), Novo Holdings A/S (2.08M shares), BOXER CAPITAL, LLC (1.78M shares), Ikarian Capital, LLC (1.74M shares), MORGAN STANLEY (727K shares), PRICE T ROWE ASSOCIATES INC /MD/ (577K shares), ORBIMED ADVISORS LLC (386K shares), Invesco Ltd. (315K shares), and MILLENNIUM MANAGEMENT LLC (308K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.